STX6 and hepatocellular carcinoma: Furthermore, rapamycin rescued the enhanced proliferative capacity of HCC cells after STX6 overexpression (Fig. 6B-D) and reduced the metastatic and invasive ability of STX6-overexpressing cells (Fig. 6E, F).